| # | Title | Journal | Year | Citations |
|---|
| 1 | How mental health care should change as a consequence of the COVID-19 pandemic | Lancet Psychiatry,the | 2020 | 1,101 |
| 2 | The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study | Lancet Psychiatry,the | 2019 | 528 |
| 3 | Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group | Molecular Psychiatry | 2018 | 522 |
| 4 | Preventive strategies for mental health | Lancet Psychiatry,the | 2018 | 390 |
| 5 | The impact of COVID-19 lockdown on child and adolescent mental health: systematic review | European Child and Adolescent Psychiatry | 2023 | 364 |
| 6 | A Histologic Scoring System for Prognosis of Patients With Alcoholic Hepatitis | Gastroenterology | 2014 | 353 |
| 7 | Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study | JAMA Psychiatry | 2018 | 235 |
| 8 | Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder | Nature Neuroscience | 2017 | 212 |
| 9 | Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics | JAMA Psychiatry | 2016 | 189 |
| 10 | Psychosocial risk factors for suicidality in children and adolescents | European Child and Adolescent Psychiatry | 2020 | 187 |
| 11 | Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis | Schizophrenia Bulletin | 2019 | 172 |
| 12 | A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality | Intensive Care Medicine | 2015 | 165 |
| 13 | Predictors of outcome in early-onset psychosis: a systematic review | NPJ Schizophrenia | 2015 | 161 |
| 14 | AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders | Nature Communications | 2019 | 150 |
| 15 | Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders | JAMA Psychiatry | 2021 | 136 |
| 16 | The identification, assessment and management of difficult-to-treat depression: An international consensus statement | Journal of Affective Disorders | 2020 | 133 |
| 17 | Treatment of negative symptoms: Where do we stand, and where do we go? | Schizophrenia Research | 2017 | 131 |
| 18 | International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method | Antimicrobial Agents and Chemotherapy | 2016 | 113 |
| 19 | De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia | Nature Neuroscience | 2020 | 100 |
| 20 | Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales | Antimicrobial Agents and Chemotherapy | 2015 | 97 |
| 21 | Magnetic Resonance Imaging and the Prediction of Outcome in First-Episode Schizophrenia: A Review of Current Evidence and Directions for Future Research | Schizophrenia Bulletin | 2015 | 94 |
| 22 | The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review | Schizophrenia Bulletin | 2015 | 93 |
| 23 | Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study | Schizophrenia Research | 2015 | 92 |
| 24 | Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte Studies | Biological Psychiatry | 2017 | 92 |
| 25 | Lessons Learned From the Coronavirus Health Crisis in Madrid, Spain: How COVID-19 Has Changed Our Lives in the Last 2 Weeks | Biological Psychiatry | 2020 | 90 |
| 26 | Cognitive effects of adjunctive N-acetyl cysteine in psychosis | Psychological Medicine | 2017 | 88 |
| 27 | Pharmacological approaches to treating negative symptoms: A review of clinical trials | Schizophrenia Research | 2013 | 80 |
| 28 | Second-Generation Antipsychotic Use in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Naïve Patients | Journal of the American Academy of Child and Adolescent Psychiatry | 2014 | 76 |
| 29 | The NOVA Score: A Proposal to Reduce the Need for Transesophageal Echocardiography in Patients With Enterococcal Bacteremia | Clinical Infectious Diseases | 2015 | 72 |
| 30 | Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study | Psychological Medicine | 2019 | 69 |
| 31 | Assessment of School Anti-Bullying Interventions | JAMA Pediatrics | 2021 | 69 |
| 32 | A quantitative approach to neuropsychiatry: The why and the how | Neuroscience and Biobehavioral Reviews | 2019 | 63 |
| 33 | Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study | Schizophrenia Research | 2014 | 59 |
| 34 | Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for the Cryptococcus neoformans-Cryptococcus gattii Species Complex Using the CLSI M27-A3 Broth Microdilution Method | Antimicrobial Agents and Chemotherapy | 2015 | 58 |
| 35 | Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case–control study | Psychological Medicine | 2021 | 58 |
| 36 | Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies—PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice | Schizophrenia Bulletin | 2020 | 56 |
| 37 | Progressive brain changes in children and adolescents with early-onset psychosis: A meta-analysis of longitudinal MRI studies | Schizophrenia Research | 2016 | 54 |
| 38 | Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome | American Journal of Medical Genetics, Part A | 2018 | 51 |
| 39 | Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis | Schizophrenia Research | 2018 | 50 |
| 40 | Altered white matter microstructure in 22q11.2 deletion syndrome: a multisite diffusion tensor imaging study | Molecular Psychiatry | 2020 | 50 |
| 41 | The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study | Schizophrenia Research | 2017 | 49 |
| 42 | The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for its Methodology and a Review of the Effectiveness of Switching Antipsychotics | Schizophrenia Bulletin | 2015 | 47 |
| 43 | Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure | Schizophrenia Bulletin | 2019 | 47 |
| 44 | Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics | Frontiers in Neuroendocrinology | 2017 | 46 |
| 45 | Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study | Schizophrenia Bulletin | 2019 | 46 |
| 46 | Early intervention in psychosis: From clinical intervention to health system implementation | Microbial Biotechnology | 2018 | 44 |
| 47 | The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study | European Child and Adolescent Psychiatry | 2017 | 43 |
| 48 | BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents | Journal of Psychopharmacology | 2016 | 41 |
| 49 | The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme | Social Psychiatry and Psychiatric Epidemiology | 2020 | 41 |
| 50 | The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis | Journal of Clinical Psychiatry | 2017 | 39 |
